Edesa Biotech launches underwritten public offering of shares, warrants

Reuters2026/08/19 20:01

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Edesa Biotech launched an underwritten public offering of common shares or pre-funded warrants with accompanying common share warrants.
Underwriters receive a 30-day option to buy up to 15% more common shares or pre-funded warrants with accompanying common share warrants.
Guggenheim Securities serves as sole book-running manager.
Net proceeds earmarked for general corporate purposes, including R&D and manufacturing expenses.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Edesa Biotech Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608191601PRIMZONEFULLFEED9813064) on August 19, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Edesa Biotech launches underwritten public offering of shares, warrants

You may also like

Crypto prices